Vaccination against H5 avian influenza virus induces long-term humoral immune responses in flamingoes (Phoenicopterus spp.)

被引:2
|
作者
Fernandez-Bellon, Hugo [1 ,2 ]
Vergara-Alert, Julia [3 ]
Almagro, Vanessa [1 ,2 ]
Rivas, Raquel [3 ]
Sanchez, Azucena [4 ]
Carmen Martinez, Maria [4 ]
Majo, Natalia [2 ,3 ]
Busquets, Nuria [3 ]
Ramis, Antonio [2 ,3 ]
机构
[1] Parc Zool Barcelona, Parc Ciutadella S-N, Barcelona 08003, Spain
[2] Univ Autonoma Barcelona, Dept Sanitat & Anat Anim, E-08193 Barcelona, Spain
[3] CReSA, IRTA, Campus Univ Autonoma Barcelona, Barcelona 08193, Spain
[4] Lab Cent Vet, Serv Virol, Ctra Algete,Km 8, Madrid 28110, Spain
关键词
Avian influenza; Zoo birds; Flamingo; Vaccination; Long-term immunity; H5N1; ZOO-BIRDS; HONG-KONG;
D O I
10.1016/j.vaccine.2016.04.078
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Avian influenza (AI) can represent a threat to endangered wild birds, as demonstrated with the H5N1 highly pathogenic AI (HPAI) outbreaks. Vaccination against AI using inactivated H5-vaccines has been shown to induce humoral immune response in zoo bird species. In this study, the long-term efficacy of H5-vaccination was evaluated in flamingoes from Barcelona Zoo. Specific H5-antibody titres were maintained at high levels (geometric mean titres >= 32) for over 7 years after vaccination, both against the H5N9 and H5N3 vaccine strains, as well as H5N3 and H5N1 reference strains. In addition the breadth of the immune response was also studied by testing antibody production against H1-, H3-, H4-, H7-, and H10 subtypes. It was observed that most flamingoes presented specific antibodies against H1 virus subtypes, but titres to the other HA-subtypes were rarely detected. We show that AI-vaccines can induce immunity lasting seven years in flamingoes, which suggests that vaccination can provide long term protection from HPAI outbreaks in zoo birds. (C) 2016 Published by Elsevier Ltd.
引用
收藏
页码:3082 / 3086
页数:5
相关论文
共 50 条
  • [31] Characterization of the In Vitro and In Vivo Efficacy of Baloxavir Marboxil against H5 Highly Pathogenic Avian Influenza Virus Infection
    Taniguchi, Keiichi
    Ando, Yoshinori
    Kobayashi, Masanori
    Toba, Shinsuke
    Nobori, Haruaki
    Sanaki, Takao
    Noshi, Takeshi
    Kawai, Makoto
    Yoshida, Ryu
    Sato, Akihiko
    Shishido, Takao
    Naito, Akira
    Matsuno, Keita
    Okamatsu, Masatoshi
    Sakoda, Yoshihiro
    Kida, Hiroshi
    VIRUSES-BASEL, 2022, 14 (01):
  • [32] Coexpression of Avian Influenza Virus H5 and N1 by Recombinant Newcastle Disease Virus and the Impact on Immune Response in Chickens
    Ramp, Kristina
    Veits, Jutta
    Deckers, Daniela
    Rudolf, Miriam
    Grund, Christian
    Mettenleiter, Thomas C.
    Roemer-Oberdoerfer, Angela
    AVIAN DISEASES, 2011, 55 (03) : 413 - 421
  • [33] Induction of a Protective Heterosubtypic Immune Response Against the Influenza Virus by using Recombinant Adenoviral Vectors Expressing Hemagglutinin of the Influenza H5 Virus
    Shmarov, M. M.
    Sedova, E. S.
    Verkhovskaya, L. V.
    Rudneva, I. A.
    Bogacheva, E. A.
    Barykova, Yu. A.
    Shcherbinin, D. N.
    Lysenko, A. A.
    Tutykhina, I. L.
    Logunov, D. Y.
    Smirnov, Yu. A.
    Naroditsky, B. S.
    Gintsburg, A. L.
    ACTA NATURAE, 2010, 2 (01): : 111 - 118
  • [34] Newcastle disease virus expressing H5 hemagglutinin gene protects chickens against Newcastle disease and avian influenza
    Veits, Jutta
    Wiesner, Dorothee
    Fuchs, Walter
    Hoffmann, Bernd
    Granzow, Harald
    Starick, Elke
    Mundt, Egbert
    Schirrmeier, Horst
    Mebatsion, Teshome
    Mettenleiter, Thomas C.
    Roemer-Oberdoerfer, Angela
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (21) : 8197 - 8202
  • [35] DNA vaccine encoding avian influenza virus H5 and Esat-6 of Mycobacterium tuberculosis improved antibody responses against AIV in chickens
    Oveissi, Sara
    Omar, Abdul Rahman
    Yusoff, Khatijah
    Jahanshiri, Fatemeh
    Hassan, Sharifah Syed
    COMPARATIVE IMMUNOLOGY MICROBIOLOGY AND INFECTIOUS DISEASES, 2010, 33 (06) : 491 - 503
  • [36] Single Dose of Attenuated Vaccinia Viruses Expressing H5 Hemagglutinin Affords Rapid and Long-Term Protection Against Lethal Infection with Highly Pathogenic Avian Influenza A H5N1 Virus in Mice and Monkeys
    Yasui, Fumihiko
    Munekata, Keisuke
    Fujiyuki, Tomoko
    Kuraishi, Takeshi
    Yamaji, Kenzaburo
    Honda, Tomoko
    Gomi, Sumiko
    Yoneda, Misako
    Sanada, Takahiro
    Ishii, Koji
    Sakoda, Yoshihiro
    Kida, Hiroshi
    Hattori, Shosaku
    Kai, Chieko
    Kohara, Michinori
    VACCINES, 2025, 13 (01)
  • [37] PROTECTION AGAINST VIRULENT H5 AVIAN INFLUENZA-VIRUS INFECTION IN CHICKENS BY AN INACTIVATED VACCINE PRODUCED WITH RECOMBINANT VACCINIA VIRUS
    DE, BK
    SHAW, MW
    ROTA, PA
    HARMON, MW
    ESPOSITO, JJ
    ROTT, R
    COX, NJ
    KENDAL, AP
    VACCINE, 1988, 6 (03) : 257 - 261
  • [38] Long-term patterns of humoral and cellular response after vaccination against influenza A (H1N1) in patients with hematologic malignancies
    Mariotti, Jacopo
    Spina, Francesco
    Carniti, Cristiana
    Anselmi, Giovanni
    Lucini, Davide
    Vendramin, Antonio
    Pregliasco, Fabrizio
    Corradini, Paolo
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2012, 89 (02) : 111 - 119
  • [39] Long-term effects of homologous and heterologous SARS-CoV-2 vaccination on humoral and cellular immune responses
    Hollstein, Moritz M.
    Muensterkoetter, Lennart
    Schoen, Michael P.
    Bergmann, Armin
    Husar, Thea M.
    Abratis, Anna
    Eidizadeh, Abass
    Dierks, Sascha
    Schaffrinski, Meike
    Zachmann, Karolin
    Schmitz, Anne
    Holsapple, Jason S.
    Stanisz-Bogeski, Hedwig
    Schanz, Julie
    Fischer, Andreas
    Gross, Uwe
    Leha, Andreas
    Zautner, Andreas E.
    Schnelle, Moritz
    Erpenbeck, Luise
    ALLERGY, 2022, 77 (08) : 2560 - 2564
  • [40] Preparation, characterization, and immunogenicity in mice of a recombinant influenza H5 hemagglutinin vaccine against the avian H5N1 A/Vietnam/1203/2004 influenza virus
    Biesova, Zuzana
    Miller, Mark A.
    Schneerson, Rachel
    Shiloach, Joseph
    Green, Kim Y.
    Robbins, John B.
    Keith, Jerry M.
    VACCINE, 2009, 27 (44) : 6234 - 6238